Annual EBITDA
-$15.88 M
+$13.08 M+45.17%
December 31, 2023
Summary
- As of February 7, 2025, TMDX annual EBITDA is -$15.88 million, with the most recent change of +$13.08 million (+45.17%) on December 31, 2023.
- During the last 3 years, TMDX annual EBITDA has risen by +$7.27 million (+31.42%).
- TMDX annual EBITDA is now at all-time high.
Performance
TMDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$13.04 M
-$7.34 M-36.00%
September 30, 2024
Summary
- As of February 7, 2025, TMDX quarterly EBITDA is $13.04 million, with the most recent change of -$7.34 million (-36.00%) on September 30, 2024.
- Over the past year, TMDX quarterly EBITDA has increased by +$34.48 million (+160.80%).
- TMDX quarterly EBITDA is now -36.00% below its all-time high of $20.38 million, reached on June 30, 2024.
Performance
TMDX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$64.78 M
+$34.48 M+113.83%
September 30, 2024
Summary
- As of February 7, 2025, TMDX TTM EBITDA is $64.78 million, with the most recent change of +$34.48 million (+113.83%) on September 30, 2024.
- Over the past year, TMDX TTM EBITDA has increased by +$87.97 million (+379.40%).
- TMDX TTM EBITDA is now at all-time high.
Performance
TMDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TMDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.2% | +160.8% | +379.4% |
| 3 y3 years | +31.4% | +213.2% | +301.3% |
| 5 y5 years | +21.5% | +290.2% | +331.9% |
TMDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.7% | -36.0% | +160.8% | at high | +255.9% |
| 5 y | 5-year | at high | +58.7% | -36.0% | +160.8% | at high | +255.9% |
| alltime | all time | at high | +58.7% | -36.0% | +160.8% | at high | +255.9% |
TransMedics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.04 M(-36.0%) | $64.78 M(+113.8%) |
| Jun 2024 | - | $20.38 M(+0.4%) | $30.30 M(+136.0%) |
| Mar 2024 | - | $20.29 M(+83.3%) | $12.84 M(-266.6%) |
| Dec 2023 | -$15.88 M(-45.2%) | $11.07 M(-151.6%) | -$7.70 M(-66.8%) |
| Sep 2023 | - | -$21.45 M(-835.2%) | -$23.18 M(+210.5%) |
| Jun 2023 | - | $2.92 M(-1281.0%) | -$7.47 M(-62.9%) |
| Mar 2023 | - | -$247.00 K(-94.4%) | -$20.12 M(-30.5%) |
| Dec 2022 | -$28.96 M(-24.8%) | -$4.41 M(-23.0%) | -$28.96 M(-19.0%) |
| Sep 2022 | - | -$5.73 M(-41.1%) | -$35.76 M(-13.9%) |
| Jun 2022 | - | -$9.73 M(+7.1%) | -$41.55 M(+1.2%) |
| Mar 2022 | - | -$9.09 M(-18.9%) | -$41.06 M(+6.7%) |
| Dec 2021 | -$38.49 M | -$11.21 M(-2.7%) | -$38.49 M(+19.6%) |
| Sep 2021 | - | -$11.52 M(+24.6%) | -$32.18 M(+32.0%) |
| Jun 2021 | - | -$9.25 M(+41.9%) | -$24.37 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$6.52 M(+33.0%) | -$22.24 M(-3.9%) |
| Dec 2020 | -$23.15 M(-17.1%) | -$4.90 M(+32.1%) | -$23.15 M(-11.0%) |
| Sep 2020 | - | -$3.71 M(-47.9%) | -$26.00 M(-10.8%) |
| Jun 2020 | - | -$7.12 M(-4.2%) | -$29.15 M(-2.2%) |
| Mar 2020 | - | -$7.43 M(-4.1%) | -$29.81 M(+6.7%) |
| Dec 2019 | -$27.93 M(+38.1%) | -$7.75 M(+13.0%) | -$27.93 M(+5.4%) |
| Sep 2019 | - | -$6.85 M(-11.9%) | -$26.51 M(+13.0%) |
| Jun 2019 | - | -$7.78 M(+40.3%) | -$23.46 M(+10.1%) |
| Mar 2019 | - | -$5.55 M(-12.3%) | -$21.30 M(+5.3%) |
| Dec 2018 | -$20.23 M(+6.0%) | -$6.33 M(+66.1%) | -$20.23 M(+45.5%) |
| Sep 2018 | - | -$3.81 M(-32.3%) | -$13.90 M(+37.7%) |
| Jun 2018 | - | -$5.62 M(+25.8%) | -$10.09 M(+125.8%) |
| Mar 2018 | - | -$4.47 M | -$4.47 M |
| Dec 2017 | -$19.09 M(-15.8%) | - | - |
| Dec 2016 | -$22.66 M | - | - |
FAQ
- What is TransMedics annual EBITDA?
- What is the all time high annual EBITDA for TransMedics?
- What is TransMedics annual EBITDA year-on-year change?
- What is TransMedics quarterly EBITDA?
- What is the all time high quarterly EBITDA for TransMedics?
- What is TransMedics quarterly EBITDA year-on-year change?
- What is TransMedics TTM EBITDA?
- What is the all time high TTM EBITDA for TransMedics?
- What is TransMedics TTM EBITDA year-on-year change?
What is TransMedics annual EBITDA?
The current annual EBITDA of TMDX is -$15.88 M
What is the all time high annual EBITDA for TransMedics?
TransMedics all-time high annual EBITDA is -$15.88 M
What is TransMedics annual EBITDA year-on-year change?
Over the past year, TMDX annual EBITDA has changed by +$13.08 M (+45.17%)
What is TransMedics quarterly EBITDA?
The current quarterly EBITDA of TMDX is $13.04 M
What is the all time high quarterly EBITDA for TransMedics?
TransMedics all-time high quarterly EBITDA is $20.38 M
What is TransMedics quarterly EBITDA year-on-year change?
Over the past year, TMDX quarterly EBITDA has changed by +$34.48 M (+160.80%)
What is TransMedics TTM EBITDA?
The current TTM EBITDA of TMDX is $64.78 M
What is the all time high TTM EBITDA for TransMedics?
TransMedics all-time high TTM EBITDA is $64.78 M
What is TransMedics TTM EBITDA year-on-year change?
Over the past year, TMDX TTM EBITDA has changed by +$87.97 M (+379.40%)